Rolf Karl Richard Nilsson
Geen lopende functies
Profiel
Rolf Karl Richard Nilsson formerly worked at Arterion AB, as Chief Executive Officer from 2007 to 2013, Acosense AB, as Chief Executive Officer from 2019 to 2022, and Parans Solar Lighting AB, as Chief Technical Officer from 2015 to 2017.
Mr. Nilsson received his graduate degree from Chalmers University of Technology.
Eerdere bekende functies van Rolf Karl Richard Nilsson
| Bedrijven | Functie | Einde |
|---|---|---|
| ACOSENSE AB (PUBL) | Algemeen Directeur | 01-07-2022 |
| PARANS SOLAR LIGHTING AB (PUBL) | Hoofd Techniek/Wetenschap/O&O | 01-05-2017 |
Arterion AB
 Arterion AB BiotechnologyHealth Technology Arterion AB is a holding company that manufactures biomaterials, including artificial blood vessels, consisting of microbial derived cellulose for revascularization of patients with cardiovascular diseases. It focuses on pure uncoated cellulose grafts as replacement of human vessels, primarily as bypass grafts. Its manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus. Its use of microbial derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diameter of less than five millimeters. The company was founded on January 4, 2007 and is headquartered in Gothenburg, Sweden. | Algemeen Directeur | 01-08-2013 |
Opleiding van Rolf Karl Richard Nilsson
| Chalmers University of Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Parans Solar Lighting AB
 Parans Solar Lighting AB Miscellaneous Commercial ServicesCommercial Services Parans Solar Lighting AB engages in the development and sale of an environmental system. Its products include Parans Luminaire and Parans SP4. The company was founded in 2003 and is headquartered in Moelndal, Sweden. | Commercial Services |
Arterion AB
Arterion AB BiotechnologyHealth Technology Arterion AB is a holding company that manufactures biomaterials, including artificial blood vessels, consisting of microbial derived cellulose for revascularization of patients with cardiovascular diseases. It focuses on pure uncoated cellulose grafts as replacement of human vessels, primarily as bypass grafts. Its manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus. Its use of microbial derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diameter of less than five millimeters. The company was founded on January 4, 2007 and is headquartered in Gothenburg, Sweden. | Health Technology |
Acosense AB
 Acosense AB Electronic Equipment/InstrumentsElectronic Technology Acosense AB engages in the manufacture and trade of measuring instruments and devices. Its product, Acospector, is an online instrument that uses acoustics to analyze liquids in pipes in real time. The company was founded by David Brohall on October 7, 2009 and is headquartered in Gothenburg, Sweden. | Electronic Technology |
